Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2024)
Whitehawk Therapeutics (WHWK) reported Interest Expenses of $38000.0 for Q3 2024, down 34.48% year-over-year from $58000.0 in Q4 2023, and down 34.48% on a QoQ basis from $58000.0 in Q2 2024.
Whitehawk Therapeutics (WHWK) has 12 years of Interest Expenses data on file, last reported at $38000.0 in Q3 2024.
- Quarterly Interest Expenses fell 34.48% year-over-year to $38000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $38000.0 (down 83.55% YoY) and the FY2024 annual result came in at $154000.0, down 33.33% from the prior year.
- Interest Expenses eased to $38000.0 in Q3 2024 per WHWK's latest filing, from $58000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $284000.0 in Q4 2020 and bottomed at $38000.0 in Q3 2024.
- The 5-year median for Interest Expenses is $58000.0 (2022), against an average of $105529.4.
- The widest annual swing landed in 2021, when Interest Expenses sank 79.93%; it then changed 0.0% in 2022.
- Tracing WHWK's Interest Expenses over 5 years: stood at $284000.0 in 2020, then plunged by 79.93% to $57000.0 in 2021, then changed by 0.0% to $57000.0 in 2022, then changed by 0.0% to $57000.0 in 2023, then sank by 33.33% to $38000.0 in 2024.
- Per Business Quant, the three latest WHWK Interest Expenses figures stand at $38000.0 (Q3 2024), $58000.0 (Q2 2024), and $58000.0 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Jun 30, 2021 | 227,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Mar 31, 2021 | 224,000.00 |
| Dec 31, 2020 | 284,000.00 |
| Dec 31, 2020 | 284,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Dec 31, 2016 | 2,571.00 |
| Dec 31, 2016 | 2,571.00 |
| Sep 30, 2016 | 2,434.00 |
| Sep 30, 2016 | 2,434.00 |
| Jun 30, 2016 | 2,543.00 |
| Jun 30, 2016 | 2,543.00 |
| Mar 31, 2016 | 2,394.00 |
| Mar 31, 2016 | 2,394.00 |
| Dec 31, 2015 | 2,219.00 |
| Dec 31, 2015 | 2,219.00 |
| Sep 30, 2015 | 2,193.00 |
| Sep 30, 2015 | 2,193.00 |
| Jun 30, 2015 | 2,169.00 |
| Jun 30, 2015 | 2,169.00 |
| Mar 31, 2015 | 1,853.00 |
| Mar 31, 2015 | 1,853.00 |
| Dec 31, 2014 | 1,891.00 |
| Dec 31, 2014 | 1,891.00 |
| Sep 30, 2014 | 1,663.00 |
| Sep 30, 2014 | 1,663.00 |
| Jun 30, 2014 | 1,645.00 |
| Jun 30, 2014 | 1,645.00 |
| Mar 31, 2014 | 1,628.00 |
| Mar 31, 2014 | 1,628.00 |
| Dec 31, 2013 | 1,663.00 |
| Dec 31, 2013 | 1,663.00 |
| Sep 30, 2013 | 1,664.00 |
| Sep 30, 2013 | 1,664.00 |
| Jun 30, 2013 | 1,293.00 |
| Jun 30, 2013 | 1,293.00 |
| Mar 31, 2013 | 1,257.00 |
| Mar 31, 2013 | 1,257.00 |
| Dec 31, 2012 | 1,286.00 |
| Dec 31, 2012 | 1,286.00 |
| Sep 30, 2012 | 1,285.00 |
| Sep 30, 2012 | 1,285.00 |
| Jun 30, 2012 | 1,272.00 |
| Jun 30, 2012 | 1,272.00 |
| Mar 31, 2012 | 1,131.00 |
| Mar 31, 2012 | 1,131.00 |
| Dec 31, 2011 | 908.00 |
| Dec 31, 2011 | 908.00 |
| Sep 30, 2011 | 907.00 |
| Sep 30, 2011 | 907.00 |
| Jun 30, 2011 | 898.00 |
| Jun 30, 2011 | 898.00 |
| Mar 31, 2011 | 888.00 |
| Mar 31, 2011 | 888.00 |
| Dec 31, 2010 | 532.00 |
| Dec 31, 2010 | 532.00 |
| Sep 30, 2010 | 529.00 |
| Sep 30, 2010 | 529.00 |